New Jersey-based Linus Biotechnology Inc. (LinusBio), a precision medicine startup, just launched ClearStrand-ASD, a novel biomarker test for autism spectrum disorder (ASD). This first-of-its-kind diagnostic aid analyzes a single strand of hair to detect a molecular signature linked to autism. It helps doctors rule out ASD in children aged 1 to 36 months when autism … First-of-its-Kind Diagnostic Aid Uses a Single Hair Strand to Detect Autism Risk in Babies Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.